Marvell Technology, Inc. filings document the company’s operating results, capital-markets activity and governance matters as a Nasdaq-listed semiconductor issuer. Recent 8-K disclosures cover quarterly and fiscal-year results, dividend declarations, senior note financing under an automatic shelf registration statement, prospectus supplement exhibits and related legal opinions.
The filings also describe MRVL capital-structure changes, including Series A Convertible Preferred Stock issued to NVIDIA Corporation, certificate of designation terms, debt indenture provisions and unregistered common-stock issuances tied to the completed Celestial AI acquisition. These records address securities registration, financing terms, conversion mechanics, exhibits and other material events affecting the company’s equity and debt structure.
Marvell Technology, Inc. (MRVL) reported an insider equity transaction by its EVP & Chief Legal Officer, Mark Casper. On 11/15/2025, 2,486 Restricted Stock Units were converted into an equal number of shares of common stock at an exercise price of $0 under transaction code "M". On the same date, 1,233 shares were disposed of at $86.45 under code "F" to cover tax withholding due on the RSU vesting. Following these transactions, Casper directly beneficially owned 10,275 shares of common stock and indirectly owned 17,163 shares through the Mark J. Casper and Stephanie Casper Revocable Trust for the benefit of his immediate family. The RSU award fully vested on November 15, 2025.
Marvell Technology (MRVL) reported insider activity by its Chairman of the Board and CEO. On 10/15/2025, multiple RSU vestings delivered 5,519, 6,969, and 8,409 shares, with share surrenders for tax withholding of 2,906, 3,670, and 4,428 at $88.89.
On 10/17/2025, the reporting person made a bona fide charitable gift of 22,722 shares. Following these transactions, directly beneficially owned shares were 255,808.
Marvell Technology (MRVL) insider Christopher R. Koopmans, President and COO, reported routine equity transactions on 10/15/2025. Restricted Stock Units vested and were settled into 11,362 shares of Common Stock at $0, held indirectly by the Koopmans Family Trust. To cover tax withholding from the vesting, the trust surrendered 5,635 shares at a price of $88.89 per share.
Following these transactions, the trust beneficially owned 110,552 shares. The filing notes remaining RSU tranches scheduled to vest on specified dates from January 15, 2026 through April 15, 2028.
Marvell Technology (MRVL) executive Mark J. Casper, EVP & Chief Legal Officer, reported RSU conversions to common stock and related tax-withholding share surrenders on 10/15/2025. Multiple RSU tranches were converted to common at $0 (codes M), and shares were withheld for taxes at $88.89 per share (code F).
Following these transactions, he held 9,022 shares directly and 17,163 shares indirectly via a trust. Derivative holdings showed 15,290 Restricted Stock Units beneficially owned after the reported transactions. Notes indicate additional RSU vesting dates extending through April 15, 2028.
Marvell Technology (MRVL) insider filed a Form 4 reporting RSU vesting and tax withholdings. On 10/15/2025, the company’s President, Data Center Group, reported multiple Restricted Stock Unit conversions to common stock (codes M) and share surrenders for tax withholding (code F) at $88.89.
RSU conversions added 3,680, 2,462, 3,567, and 1,757 shares at no cost, with corresponding tax-withholding surrenders of 1,938, 1,297, 1,879, and 926 shares. Each RSU equals one MRVL share upon vesting. Remaining RSUs are scheduled to vest on stated dates through April 15, 2028, including tranches on January 15 and April 15, 2026; quarterly dates through 2027; and January 15 and April 15, 2028.
Marvell Technology (MRVL) — CFO equity activity: The Chief Financial Officer reported multiple Restricted Stock Unit (RSU) vestings on 10/15/2025 (transaction code M), delivering 2,551, 3,434, 2,556, and 3,822 shares of common stock at an exercise price of $0.
To satisfy tax withholding (code F), the filer surrendered 1,062, 1,428, 1,062, and 1,604 shares at a price of $88.89. Following these transactions, the filer beneficially owned 139,366 shares of common stock directly. Derivative holdings shown as beneficially owned after the transactions were 38,222 RSUs. The remaining RSUs are scheduled to vest on specified dates through April 15, 2028.
Marvell Technology, Inc. reported that several top executives bought its common stock in open-market transactions on September 25, 2025. Chairman and CEO Matt Murphy purchased 13,600 shares at a weighted average price of $77.09 per share.
President and COO Chris Koopmans bought 6,800 shares at a weighted average price of $78.03, while President, Data Center Group, Sandeep Bharathi and Chief Financial Officer Willem Meintjes each acquired 3,400 shares at a weighted average price of $78.03. These purchases were made personally by the executives in the market.
Marvell Technology, Inc. (MRVL) Form 4: The reporting person, Willem A. Meintjes, identified as the company's Chief Financial Officer, purchased 3,400 shares of Marvell common stock on 09/25/2025 at a price of $78.03 per share. Following this transaction, the reporting person beneficially owned 132,159 shares. The filing notes the purchase was matchable under Section 16(b) but there were no profits to disgorge. The Form 4 was signed on behalf of Mr. Meintjes by an attorney-in-fact, Blair Walters.
Marvell Technology insider purchase reported: The Form 4 shows that Sandeep Bharathi, President of the Data Center Group and an officer of Marvell Technology, acquired 3,400 shares of Marvell common stock at a price of $78.03 per share on 09/25/2025. After this transaction, the reporting person beneficially owned 73,392 shares of the company's common stock. The filer notes the purchase was matchable under Section 16(b) but states no profits were disgorged.
Christopher R. Koopmans, President and COO of Marvell Technology, Inc. (MRVL), purchased 6,800 shares of Marvell common stock on 09/25/2025 at a price of $78.03 per share. After the reported purchase, the filing shows beneficial ownership of 104,825 shares held indirectly through the Christopher R. Koopmans and Heather J. Koopmans Family Trust. The Form 4 notes the purchase was matchable under Section 16(b) but no profits were required to be disgorged. The filing was signed by an attorney-in-fact on behalf of Mr. Koopmans.